Funding news
CRISPR Therapeutics logo

CRISPR Therapeutics Raises $100K

Recently funded · $100.0K UnknownHospitals and Health CareUSView source

Get the full CRISPR Therapeutics company profile

Access contacts, investors, buying signals & more

Open in Dashboard

The company that brought the world its first approved CRISPR-based therapy, CRISPR Therapeutics, has raised $100K in new capital. Known for its pioneering work in gene editing, the firm celebrated the historic approval of CASGEVY® in late 2023, a treatment for eligible patients with sickle cell disease and transfusion-dependent beta thalassemia.

CRISPR Therapeutics has evolved significantly since its inception over a decade ago, advancing a diverse portfolio of product candidates across hemoglobinopathies, oncology, regenerative medicine, cardiovascular, autoimmune, and rare diseases. The Swiss-headquartered company, with R&D operations in Boston and San Francisco, continues to leverage Nobel Prize-winning technology and strategic partnerships, including one with Vertex Pharmaceuticals, to develop potentially transformative medicines.

Other United States companies recently funded

View all

Biggest recent Biotechnology rounds

Largest funding rounds in Biotechnology on Signalbase right now.

#CompanyAmount
1
Shockwave Medical logo

Shockwave Medical

United States

$13.1B
2
NeuroEM Therapeutics logo

NeuroEM Therapeutics

United States

$7.2B
3
Illumina logo

Illumina

United States

$7.1B
4
GRAIL logo

GRAIL

United States

$7.1B
5
RemeGen Biosciences logo

RemeGen Biosciences

United States

$5.6B

Other recent Unknown rounds

Companies that recently closed a Unknown round.

#CompanyAmount
1
VOY logo

VOY

Germany

$100.0K
2
seca – precision for health logo

seca – precision for health

Germany

$100.0K
3
Finculators logo

Finculators

India

$100.0K
4
Tax Calculator logo

Tax Calculator

United States

$100.0K
5
Investor Summit Group logo

Investor Summit Group

United States

$100.0K